【ABC-KY】Announcement by Subsidiary Applied BioCode, Inc. that its 20-item Respiratory Pathogen Panel (RPP) and Automated Diagnostic System (MDx3000), combined with Thermo Fisher Scientific's KingFisher extraction instrument pre-processing system, have obtained US FDA market clearance.
NQ Score
0/100
N1 Content Completeness
5
AI Summary (NQ-processed)
ABC-KY's subsidiary, Applied BioCode, Inc., announced that its 20-item Respiratory Pathogen Panel (RPP) and Automated Diagnostic System (MDx3000), in combination with Thermo Fisher Scientific's KingFisher extraction instrument pre-processing system, have received US FDA 510(k) market clearance. This grants sales qualification in the US and is expected to positively impact the company's finances and operations.